SBIR Phase I: Development of rod-shaped drug delivery nanoparticles for in-space manufactu — NSF Award to EASCRA BIOTECH, INC. (RI
The broader impact of this Small Business Innovation Research (SBIR) Phase I project is its potential to transform the solid tumor cancer treatment market, projected to reach $424.6 billion by 2027. The project aims to advance the regulatory pathway for space-made medicines by using Janus base nanoparticles (JBNps) as
| Award title | SBIR Phase I: Development of rod-shaped drug delivery nanoparticles for in-space manufactu |
|---|---|
| Award ID | 2415574 |
| Awardee | EASCRA BIOTECH, INC. |
| City | PAWTUCKET |
| State | RI |
| Amount obligated | $274,990 |
| Principal investigator | Mari Anne Snow |
| Program | SBIR Phase I |
| Start date | 12/15/2024 |
| Abstract | The broader impact of this Small Business Innovation Research (SBIR) Phase I project is its potential to transform the solid tumor cancer treatment market, projected to reach $424.6 billion by 2027. The project aims to advance the regulatory pathway for space-made medicines by using Janus base nanoparticles (JBNps) as a test case to demonstrate comparability with Earth-made versions. This step is crucial for the commercialization of space-made therapeutics, addressing challenges in drug delivery |
| Source | NSF Awards |
$799/mo
Try NSFGrants →